Breaking News Instant updates and real-time market news.

RIO

Rio Tinto

$69.32 /

+0.7 (+1.02%)

14:07
12/01/22
12/01
14:07
12/01/22
14:07

Rio Tinto downgraded to Neutral at Citi after Capital Markets Day

Citi analyst Ephrem Ravi downgraded Rio Tinto to Neutral from Buy with a price target of 5,800 GBp, down from 6,000 GBp, as he lowered his calendar year 2023 and 2024 EPS estimates by 11% and 6%, respectively, following the company's Capital Markets Day. Rio shares are up 28% since the end of October amid a "market euphoria around potential China reopening," but Ravi thinks China reopening is a second half of 2023 event and in the meantime says there is a "sharp ex-China downturn" in steel production to navigate.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Clorox sees FX headwinds a a 2-point reduction in FY23 sales » 16:13
02/02/23
02/02
16:13
02/02/23
16:13
CLX

Clorox

$140.87 /

-3.41 (-2.36%)

The company is confirming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLX Clorox
$140.87 /

-3.41 (-2.36%)

CLX Clorox
$140.87 /

-3.41 (-2.36%)

02/01/23 Jefferies
Clorox price target raised to $145 from $140 at Jefferies
01/13/23 JPMorgan
Clorox price target raised to $135 from $126 at JPMorgan
12/06/22 Deutsche Bank
Clorox price target raised to $151 from $148 at Deutsche Bank
11/02/22 DA Davidson
Clorox price target raised to $155 from $124 at DA Davidson
CLX Clorox
$140.87 /

-3.41 (-2.36%)

CLX Clorox
$140.87 /

-3.41 (-2.36%)

CLX Clorox
$140.87 /

-3.41 (-2.36%)

Earnings
Cavco Industries reports Q3 EPS $6.66, consensus $5.79 » 16:13
02/02/23
02/02
16:13
02/02/23
16:13
CVCO

Cavco Industries

$277.81 /

+3.2 (+1.17%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVCO Cavco Industries
$277.81 /

+3.2 (+1.17%)

CVCO Cavco Industries
$277.81 /

+3.2 (+1.17%)

12/30/22 Wedbush
Wedbush favors four homebuilding stocks heading into 2023
11/07/22 Craig-Hallum
Cavco Industries price target lowered to $290 from $335 at Craig-Hallum
08/08/22 Craig-Hallum
Cavco Industries price target raised to $335 from $322 at Craig-Hallum
08/05/22 Wedbush
Cavco Industries upgraded to Outperform from Neutral at Wedbush
CVCO Cavco Industries
$277.81 /

+3.2 (+1.17%)

Hot Stocks
Bill.com announces $300M share repurchase program » 16:13
02/02/23
02/02
16:13
02/02/23
16:13
BILL

Bill.com

$129.04 /

+10 (+8.40%)

Bill.com announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BILL Bill.com
$129.04 /

+10 (+8.40%)

BILL Bill.com
$129.04 /

+10 (+8.40%)

01/30/23 KeyBanc
Bill.com price target raised to $130 from $125 at KeyBanc
01/27/23 Citi
Bill.com initiated with a Buy at Citi
01/24/23 Deutsche Bank
Bill.com price target lowered to $150 from $200 at Deutsche Bank
01/12/23 Oppenheimer
Bill.com price target lowered to $150 from $180 at Oppenheimer
BILL Bill.com
$129.04 /

+10 (+8.40%)

BILL Bill.com
$129.04 /

+10 (+8.40%)

BILL Bill.com
$129.04 /

+10 (+8.40%)

Hot Stocks
WWE sees FY23 adjusted OIBDA $395M-$410M » 16:12
02/02/23
02/02
16:12
02/02/23
16:12
WWE

WWE

$85.26 /

-0.91 (-1.06%)

The company also expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

01/31/23 Wolfe Research
Wolfe Research says WWE not downgraded in correction note
01/31/23 Wolfe Research
WWE downgraded to Peer Perform on signs of 'stress' at Wolfe Research
01/30/23 Wolfe Research
WWE downgraded to Peer Perform from Outperform at Wolfe Research
01/17/23 Wells Fargo
WWE upgraded to Equal Weight from Underweight at Wells Fargo
WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

Initiation
C3.ai initiated with a Buy at DA Davidson » 16:12
02/02/23
02/02
16:12
02/02/23
16:12
AI

C3.ai

$21.97 /

+0.305 (+1.41%)

DA Davidson analyst Gil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AI C3.ai
$21.97 /

+0.305 (+1.41%)

AI C3.ai
$21.97 /

+0.305 (+1.41%)

12/08/22 Morgan Stanley
C3.ai price target lowered to $12 from $13 at Morgan Stanley
12/08/22 Piper Sandler
C3.ai price target lowered to $13 from $14 at Piper Sandler
12/08/22 Deutsche Bank
C3.ai price target lowered to $11 from $13 at Deutsche Bank
12/08/22 JMP Securities
C3.ai price target lowered to $19 from $25 at JMP Securities
AI C3.ai
$21.97 /

+0.305 (+1.41%)

AI C3.ai
$21.97 /

+0.305 (+1.41%)

AI C3.ai
$21.97 /

+0.305 (+1.41%)

Earnings
WWE reports Q4 EPS 45c, consensus 58c » 16:12
02/02/23
02/02
16:12
02/02/23
16:12
WWE

WWE

$85.26 /

-0.91 (-1.06%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

01/31/23 Wolfe Research
Wolfe Research says WWE not downgraded in correction note
01/31/23 Wolfe Research
WWE downgraded to Peer Perform on signs of 'stress' at Wolfe Research
01/30/23 Wolfe Research
WWE downgraded to Peer Perform from Outperform at Wolfe Research
01/17/23 Wells Fargo
WWE upgraded to Equal Weight from Underweight at Wells Fargo
WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

WWE WWE
$85.26 /

-0.91 (-1.06%)

Earnings
Bill.com raises FY23 EPS view to 99c-$1.05 from 48c-59c, consensus 55c » 16:12
02/02/23
02/02
16:12
02/02/23
16:12
BILL

Bill.com

$129.06 /

+10.02 (+8.42%)

Raises FY23 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BILL Bill.com
$129.06 /

+10.02 (+8.42%)

BILL Bill.com
$129.06 /

+10.02 (+8.42%)

01/30/23 KeyBanc
Bill.com price target raised to $130 from $125 at KeyBanc
01/27/23 Citi
Bill.com initiated with a Buy at Citi
01/24/23 Deutsche Bank
Bill.com price target lowered to $150 from $200 at Deutsche Bank
01/12/23 Oppenheimer
Bill.com price target lowered to $150 from $180 at Oppenheimer
BILL Bill.com
$129.06 /

+10.02 (+8.42%)

BILL Bill.com
$129.06 /

+10.02 (+8.42%)

BILL Bill.com
$129.06 /

+10.02 (+8.42%)

Earnings
Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22 » 16:11
02/02/23
02/02
16:11
02/02/23
16:11
CLX

Clorox

$140.99 /

-3.29 (-2.28%)

FY23 consensus $4.17.FY23…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLX Clorox
$140.99 /

-3.29 (-2.28%)

CLX Clorox
$140.99 /

-3.29 (-2.28%)

02/01/23 Jefferies
Clorox price target raised to $145 from $140 at Jefferies
01/13/23 JPMorgan
Clorox price target raised to $135 from $126 at JPMorgan
12/06/22 Deutsche Bank
Clorox price target raised to $151 from $148 at Deutsche Bank
11/02/22 DA Davidson
Clorox price target raised to $155 from $124 at DA Davidson
CLX Clorox
$140.99 /

-3.29 (-2.28%)

CLX Clorox
$140.99 /

-3.29 (-2.28%)

CLX Clorox
$140.99 /

-3.29 (-2.28%)

Earnings
Good Times Restaurants reports Q1 EPS (1c) vs. 3c y/y » 16:11
02/02/23
02/02
16:11
02/02/23
16:11
GTIM

Good Times Restaurants

$3.00 /

+0.095 (+3.27%)

Reports Q1 revenue $33.4M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTIM Good Times Restaurants
$3.00 /

+0.095 (+3.27%)

Earnings
Bill.com sees Q3 adjusted EPS 22c-25c, consensus 12c » 16:11
02/02/23
02/02
16:11
02/02/23
16:11
BILL

Bill.com

$128.96 /

+9.92 (+8.33%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BILL Bill.com
$128.96 /

+9.92 (+8.33%)

BILL Bill.com
$128.96 /

+9.92 (+8.33%)

01/30/23 KeyBanc
Bill.com price target raised to $130 from $125 at KeyBanc
01/27/23 Citi
Bill.com initiated with a Buy at Citi
01/24/23 Deutsche Bank
Bill.com price target lowered to $150 from $200 at Deutsche Bank
01/12/23 Oppenheimer
Bill.com price target lowered to $150 from $180 at Oppenheimer
BILL Bill.com
$128.96 /

+9.92 (+8.33%)

BILL Bill.com
$128.96 /

+9.92 (+8.33%)

BILL Bill.com
$128.96 /

+9.92 (+8.33%)

Syndicate
Johnson Controls files automatic mixed securities shelf  16:11
02/02/23
02/02
16:11
02/02/23
16:11
JCI

Johnson Controls

$64.65 /

-1.69 (-2.55%)

 
ShowHide Related Items >><<
JCI Johnson Controls
$64.65 /

-1.69 (-2.55%)

JCI Johnson Controls
$64.65 /

-1.69 (-2.55%)

01/26/23 OTR Global
U.S. commercial HVAC equipment view upgraded at OTR Global
01/13/23 Mizuho
Johnson Controls price target raised to $78 from $72 at Mizuho
12/12/22 BofA
Johnson Controls downgraded to Neutral at BofA on HVAC end market bearishness
12/12/22 BofA
Johnson Controls downgraded to Neutral from Buy at BofA
JCI Johnson Controls
$64.65 /

-1.69 (-2.55%)

Initiation
Relay Therapeutics initiated with an Outperform at Oppenheimer » 16:11
02/02/23
02/02
16:11
02/02/23
16:11
RLAY

Relay Therapeutics

$22.76 /

+1.11 (+5.13%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RLAY Relay Therapeutics
$22.76 /

+1.11 (+5.13%)

RLAY Relay Therapeutics
$22.76 /

+1.11 (+5.13%)

01/19/23 JMP Securities
Relay Therapeutics price target lowered to $28 from $38 at JMP Securities
11/07/22 H.C. Wainwright
Relay Therapeutics price target lowered to $43 from $50 at H.C. Wainwright
09/30/22 Barclays
Relay Therapeutics initiated with an Equal Weight at Barclays
09/14/22 JMP Securities
Relay Therapeutics price target raised to $38 from $35 at JMP Securities
RLAY Relay Therapeutics
$22.76 /

+1.11 (+5.13%)

  • 13
    Sep
RLAY Relay Therapeutics
$22.76 /

+1.11 (+5.13%)

Earnings
Bill.com reports Q2 adjusted EPS 42c, consensus 13c » 16:11
02/02/23
02/02
16:11
02/02/23
16:11
BILL

Bill.com

$128.96 /

+9.92 (+8.33%)

Reports Q2 revenue $260M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BILL Bill.com
$128.96 /

+9.92 (+8.33%)

BILL Bill.com
$128.96 /

+9.92 (+8.33%)

01/30/23 KeyBanc
Bill.com price target raised to $130 from $125 at KeyBanc
01/27/23 Citi
Bill.com initiated with a Buy at Citi
01/24/23 Deutsche Bank
Bill.com price target lowered to $150 from $200 at Deutsche Bank
01/12/23 Oppenheimer
Bill.com price target lowered to $150 from $180 at Oppenheimer
BILL Bill.com
$128.96 /

+9.92 (+8.33%)

BILL Bill.com
$128.96 /

+9.92 (+8.33%)

BILL Bill.com
$128.96 /

+9.92 (+8.33%)

Earnings
Quantum sees Q4 non-GAAP EPS (4c)-2c, consensus 0c » 16:11
02/02/23
02/02
16:11
02/02/23
16:11
QMCO

Quantum

$1.84 /

-0.01 (-0.54%)

Sees Q4 revenues of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QMCO Quantum
$1.84 /

-0.01 (-0.54%)

QMCO Quantum
$1.84 /

-0.01 (-0.54%)

06/09/22 Northland
Quantum price target lowered to $6 from $7 at Northland
06/09/22 Lake Street
Quantum price target lowered to $4 from $6 at Lake Street
06/09/22 B. Riley
Quantum price target lowered to $2.75 from $4 at B. Riley
03/21/22 Northland
Quantum price target lowered to $7 from $10 at Northland
QMCO Quantum
$1.84 /

-0.01 (-0.54%)

Earnings
Paylocity sees FY23 revenue $1.156B-$1.161B, consensus $1.12B » 16:10
02/02/23
02/02
16:10
02/02/23
16:10
PCTY

Paylocity

$226.18 /

+6.58 (+3.00%)

Sees FY23 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCTY Paylocity
$226.18 /

+6.58 (+3.00%)

11/04/22 KeyBanc
Paylocity price target lowered to $295 from $310 at KeyBanc
10/28/22 DA Davidson
Paylocity cut to Neutral at DA Davidson on valuation, expectations for softer Q1
10/28/22 DA Davidson
Paylocity downgraded to Neutral from Buy at DA Davidson
10/24/22 Needham
Needham adds Five9 to Conviction List, removes Paylocity
PCTY Paylocity
$226.18 /

+6.58 (+3.00%)

Earnings
Atlassian sees Q3 revenue $890M-$910M, consensus $900.92M » 16:10
02/02/23
02/02
16:10
02/02/23
16:10
TEAM

Atlassian

$181.51 /

+11.26 (+6.61%)

Gross margin is expected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

01/30/23 Barclays
Zoom Video raising prices for Zoom One Pro, says Barclays
01/19/23 Jefferies
Atlassian price target raised to $180 from $150 at Jefferies
01/11/23 Mizuho
Atlassian significantly raised prices yesterday, says Mizuho
01/05/23 Jefferies
Atlassian upgraded to Buy from Hold at Jefferies
TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

Hot Stocks
Gilead raises quarterly dividend 2.7% to 75c per share » 16:10
02/02/23
02/02
16:10
02/02/23
16:10
GILD

Gilead

$81.11 /

-2.885 (-3.43%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$81.11 /

-2.885 (-3.43%)

GILD Gilead
$81.11 /

-2.885 (-3.43%)

01/30/23 Truist
Truist sees potential pressure on Seagen's Padcev in Q4
01/19/23 Piper Sandler
Gilead price target raised to $111 from $104 at Piper Sandler
01/03/23 RBC Capital
RBC downgrades Gilead, says drivers need time to play out
01/03/23 RBC Capital
Gilead downgraded to Sector Perform from Outperform at RBC Capital
GILD Gilead
$81.11 /

-2.885 (-3.43%)

GILD Gilead
$81.11 /

-2.885 (-3.43%)

GILD Gilead
$81.11 /

-2.885 (-3.43%)

Earnings
Clorox reports Q2 adjusted EPS 98c, consensus 65c » 16:10
02/02/23
02/02
16:10
02/02/23
16:10
CLX

Clorox

$141.07 /

-3.21 (-2.22%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLX Clorox
$141.07 /

-3.21 (-2.22%)

CLX Clorox
$141.07 /

-3.21 (-2.22%)

02/01/23 Jefferies
Clorox price target raised to $145 from $140 at Jefferies
01/13/23 JPMorgan
Clorox price target raised to $135 from $126 at JPMorgan
12/06/22 Deutsche Bank
Clorox price target raised to $151 from $148 at Deutsche Bank
11/02/22 DA Davidson
Clorox price target raised to $155 from $124 at DA Davidson
CLX Clorox
$141.07 /

-3.21 (-2.22%)

CLX Clorox
$141.07 /

-3.21 (-2.22%)

CLX Clorox
$141.07 /

-3.21 (-2.22%)

Earnings
Atlassian sees FY23 revenue growth y/y 25%, consensus $3.49B » 16:10
02/02/23
02/02
16:10
02/02/23
16:10
TEAM

Atlassian

$181.51 /

+11.26 (+6.61%)

Cloud revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

01/30/23 Barclays
Zoom Video raising prices for Zoom One Pro, says Barclays
01/19/23 Jefferies
Atlassian price target raised to $180 from $150 at Jefferies
01/11/23 Mizuho
Atlassian significantly raised prices yesterday, says Mizuho
01/05/23 Jefferies
Atlassian upgraded to Buy from Hold at Jefferies
TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

TEAM Atlassian
$181.51 /

+11.26 (+6.61%)

Hot Stocks
Atlassian board authorized program to repurchase up to $1B of stock » 16:09
02/02/23
02/02
16:09
02/02/23
16:09
TEAM

Atlassian

$181.25 /

+11 (+6.46%)

In January 2023, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$181.25 /

+11 (+6.46%)

TEAM Atlassian
$181.25 /

+11 (+6.46%)

01/30/23 Barclays
Zoom Video raising prices for Zoom One Pro, says Barclays
01/19/23 Jefferies
Atlassian price target raised to $180 from $150 at Jefferies
01/11/23 Mizuho
Atlassian significantly raised prices yesterday, says Mizuho
01/05/23 Jefferies
Atlassian upgraded to Buy from Hold at Jefferies
TEAM Atlassian
$181.25 /

+11 (+6.46%)

TEAM Atlassian
$181.25 /

+11 (+6.46%)

TEAM Atlassian
$181.25 /

+11 (+6.46%)

Initiation
Tyra Biosciences initiated with an Outperform at Oppenheimer » 16:09
02/02/23
02/02
16:09
02/02/23
16:09
TYRA

Tyra Biosciences

$12.66 /

-0.76 (-5.66%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TYRA Tyra Biosciences
$12.66 /

-0.76 (-5.66%)

TYRA Tyra Biosciences
$12.66 /

-0.76 (-5.66%)

06/23/22 H.C. Wainwright
Tyra Biosciences initiated with a Buy at H.C. Wainwright
03/08/22 Jefferies
Jefferies upgrades Tyra Biosciences to Buy on valuation after 58% pullback
03/08/22 Jefferies
Tyra Biosciences upgraded to Buy from Hold at Jefferies
TYRA Tyra Biosciences
$12.66 /

-0.76 (-5.66%)

TYRA Tyra Biosciences
$12.66 /

-0.76 (-5.66%)

Earnings
Paylocity sees Q3 revenue $330.5M-$334.5M, consensus $318.65M » 16:09
02/02/23
02/02
16:09
02/02/23
16:09
PCTY

Paylocity

$225.70 /

+6.1 (+2.78%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCTY Paylocity
$225.70 /

+6.1 (+2.78%)

11/04/22 KeyBanc
Paylocity price target lowered to $295 from $310 at KeyBanc
10/28/22 DA Davidson
Paylocity cut to Neutral at DA Davidson on valuation, expectations for softer Q1
10/28/22 DA Davidson
Paylocity downgraded to Neutral from Buy at DA Davidson
10/24/22 Needham
Needham adds Five9 to Conviction List, removes Paylocity
PCTY Paylocity
$225.70 /

+6.1 (+2.78%)

Earnings
Quantum reports Q3 non-GAAP EPS 2c, consensus 0c » 16:09
02/02/23
02/02
16:09
02/02/23
16:09
QMCO

Quantum

$1.83 /

-0.02 (-1.08%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QMCO Quantum
$1.83 /

-0.02 (-1.08%)

QMCO Quantum
$1.83 /

-0.02 (-1.08%)

06/09/22 Northland
Quantum price target lowered to $6 from $7 at Northland
06/09/22 Lake Street
Quantum price target lowered to $4 from $6 at Lake Street
06/09/22 B. Riley
Quantum price target lowered to $2.75 from $4 at B. Riley
03/21/22 Northland
Quantum price target lowered to $7 from $10 at Northland
QMCO Quantum
$1.83 /

-0.02 (-1.08%)

Earnings
Atlassian reports Q2 adjusted EPS 45c, consensus 31c » 16:09
02/02/23
02/02
16:09
02/02/23
16:09
TEAM

Atlassian

$181.25 /

+11 (+6.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$181.25 /

+11 (+6.46%)

TEAM Atlassian
$181.25 /

+11 (+6.46%)

01/30/23 Barclays
Zoom Video raising prices for Zoom One Pro, says Barclays
01/19/23 Jefferies
Atlassian price target raised to $180 from $150 at Jefferies
01/11/23 Mizuho
Atlassian significantly raised prices yesterday, says Mizuho
01/05/23 Jefferies
Atlassian upgraded to Buy from Hold at Jefferies
TEAM Atlassian
$181.25 /

+11 (+6.46%)

TEAM Atlassian
$181.25 /

+11 (+6.46%)

TEAM Atlassian
$181.25 /

+11 (+6.46%)

Hot Stocks
Exponent increases quarterly dividend payment from 24c to 26c per share » 16:09
02/02/23
02/02
16:09
02/02/23
16:09
EXPO

Exponent

$105.00 /

+1.45 (+1.40%)

Exponent announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPO Exponent
$105.00 /

+1.45 (+1.40%)

EXPO Exponent
$105.00 /

+1.45 (+1.40%)

04/05/22 Truist
Exponent price target raised to $120 from $115 at Truist
EXPO Exponent
$105.00 /

+1.45 (+1.40%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.